{Reference Type}: Journal Article
{Title}: Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial.
{Author}: Chitra S;Hinahara J;Goss TF;Gunter K;LaPensee K;
{Journal}: Open Forum Infect Dis
{Volume}: 8
{Issue}: 10
{Year}: Oct 2021
{Factor}: 4.423
{DOI}: 10.1093/ofid/ofab459
{Abstract}: This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.